Posted by Michael Wonder on 22 Apr 2025
EMA publishes agenda for 22-25 April 2025 CHMP meeting
22 April 2025 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Vanzacaftor with tezacaftor and deutivacaftor
- Levacetylleucine
- Trastuzumab
- Denosumab
- Diflunisal
- Givinostat
- Resminostat
- Octreotide acetate
- Sepiapterin
- Teprotumumab
- Clascoterone
- Zanidatamab
